T63.484D

✓ Billable

Toxic effect of venom of other arthropod, undetermined, subsequent encounter

Injury, poisoning and certain other consequences of external causes (S00-T88)

Check This Code

⚠️ Excludes2

inherited

Rules inherited from parent codes.

  • ingestion of toxic animal or plant (T61.-, T62.-)

📋 Code Instructions

inherited
  • code, if applicable, for anaphylactic shock (T78.2)

Clinical Description

ICD-10-CM code T63.484D represents toxic effect of venom of other arthropod, undetermined, subsequent encounter. This code falls under the Injury, poisoning and certain other consequences of external causes (S00-T88) classification. It is a billable/specific code valid for HIPAA-covered transactions as of October 1, 2025 (FY2026). This code can be used to indicate a diagnosis for reimbursement purposes on insurance claims.

This is a 8-character code at the 7th level of specificity. This is the most specific code available in this subcategory.

Frequently Asked Questions

What is ICD-10 code T63.484D?

ICD-10-CM code T63.484D is "Toxic effect of venom of other arthropod, undetermined, subsequent encounter". It belongs to the category: Injury, poisoning and certain other consequences of external causes (S00-T88).

Is T63.484D a billable ICD-10 code?

Yes, T63.484D is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Can T63.484D be coded with other codes?

T63.484D has 1 Excludes2 note(s). These conditions can be coded together if both are documented in the patient record.

Related Codes in T63.484

Other codes in the same category that may be relevant for differential coding:

🧪 Validate Combinations

Add T63.484D to the Excludes Checker to validate against your full code list.

Open in Checker →

Code Information

CodeT63.484D
BillableYes
ParentT63.484
CategoryInjury, poisoning and certain other consequences of external causes (S00-T88)
Excludes10 rule(s)
Excludes21 note(s)

Data Source

CMS ICD-10-CM 2026 Tabular List

Updated October 1, 2025 (FY2026)